Bioanalysis services: support a wide range of biopharmaceutical modalities, including monoclonal antibodies, bispecific antibodies, antibody-drug conjugates (ADCs), nucleic acid drugs/mRNA vaccines, oncolytic viruses (OVs), AAV gene therapy products (GTs), cell therapy products (e.g., CAR-T/iPSCs), fusion proteins, peptides, and small molecule drugs.

A leading enterprise dedicated to covering the entire biopharmaceutical analysis industry chain.

We provide one-stop services for critical reagent development from preclinical research to clinical bioanalysis, aiming to better meet your needs in various development stages and application scenarios, and accelerate your drug bioanalysis process comprehensively.